Blockchain Transforming Big Pharma

Description:

The complexity of data sharing, lack of visibility, coordination and trust between patients and pharmaceutical companies make drug development process expensive and ineffective. We will examine the current state of blockchain and specific use cases in pharmaceutical industry, attempting to democratize drug development. Optimized patient consent, clinical trial recruitment and retention, clinical data immutability and drug supply chain will lead to improvement in research and lowering of drug costs.